Analyzing ADM Tronics Unlimited (OTCMKTS:ADMT) & 908 Devices (NASDAQ:MASS)

ADM Tronics Unlimited (OTCMKTS:ADMTGet Free Report) and 908 Devices (NASDAQ:MASSGet Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.

Risk & Volatility

ADM Tronics Unlimited has a beta of 0.15, suggesting that its share price is 85% less volatile than the S&P 500. Comparatively, 908 Devices has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500.

Insider & Institutional Ownership

88.1% of 908 Devices shares are held by institutional investors. 73.0% of ADM Tronics Unlimited shares are held by insiders. Comparatively, 23.7% of 908 Devices shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares ADM Tronics Unlimited and 908 Devices”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ADM Tronics Unlimited $3.20 million 1.87 -$120,000.00 N/A N/A
908 Devices $59.63 million 4.73 -$72.21 million ($0.54) -14.57

ADM Tronics Unlimited has higher earnings, but lower revenue than 908 Devices.

Profitability

This table compares ADM Tronics Unlimited and 908 Devices’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ADM Tronics Unlimited -2.05% -7.88% -3.00%
908 Devices -30.54% -24.30% -18.55%

Analyst Recommendations

This is a summary of current recommendations and price targets for ADM Tronics Unlimited and 908 Devices, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ADM Tronics Unlimited 0 0 0 0 0.00
908 Devices 1 0 3 1 2.80

908 Devices has a consensus price target of $8.00, suggesting a potential upside of 1.65%. Given 908 Devices’ stronger consensus rating and higher probable upside, analysts clearly believe 908 Devices is more favorable than ADM Tronics Unlimited.

Summary

908 Devices beats ADM Tronics Unlimited on 8 of the 13 factors compared between the two stocks.

About ADM Tronics Unlimited

(Get Free Report)

ADM Tronics Unlimited, Inc., through its subsidiaries, develops, manufactures, and sells electronics for non-invasive medical and other applications in the United States, Australia, Asia, and Europe. It operates through Chemical, Electronics, and Engineering segments. The company offers proprietary devices for use in diagnostics and therapeutics of humans and animals; and electronic controllers for spas and hot tubs. In addition, the company provides water-based primers and adhesives; water-based coatings and resins; water-based chemical additives; and anti-static conductive paints, coatings, and other products. Further, it offers water-based, adhesive and related topical formulations for use in maxillofacial prosthetic medical applications; and for professional makeup applications primarily for film, TV, and theatrical productions. Additionally, the company provides research, development, regulatory, and engineering services for the design, development, and manufacturing of medical devices, electronics, and other technologies and products, as well as medical electronic therapeutic technology. ADM Tronics Unlimited, Inc. was incorporated in 1969 and is headquartered in Northvale, New Jersey.

About 908 Devices

(Get Free Report)

908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Receive News & Ratings for ADM Tronics Unlimited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADM Tronics Unlimited and related companies with MarketBeat.com's FREE daily email newsletter.